Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

105
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
105
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

135
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
135
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

25
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
25
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

41
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
41
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The extracellular matrix Piezo1 feedback loop drives renal fibrosis through compartment-specific mechanotransduction.

International urology and nephrology·2026
Same author

Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model.

Clinical nephrology·2026
Same author

Proteomic insights into aprotinin's immunomodulatory effects in attenuating renal fibrosis in a unilateral ureteral obstruction model.

Frontiers in immunology·2026
Same author

Novel prediction equations for appendicular skeletal muscle mass in hemodialysis patients: referenced against bioelectrical impedance analysis.

Frontiers in nutrition·2026
Same author

Plasma-Engineered LaMO<sub>3</sub> Perovskites as Catalysts for the Oxygen Evolution Reaction: Unlocking Potential by Oxygen Vacancy Modification.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

External validation of a nomogram for predicting tubulointerstitial lesions in IgA nephropathy: a cross-regional study in China.

Clinics (Sao Paulo, Brazil)·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K

La diálisis peritoneal en el lupus eritematoso sistémico neuropsiquiátrico: un informe de caso que integra las ideas

Xinyu Wang, Litian Pu, Manxia Yu

    Clinical nephrology
    |September 5, 2025
    PubMed
    Resumen
    Este resumen es generado por máquina.

    La diálisis peritoneal (PD) ofrece una nueva terapia dual para el lupus eritematoso neuropsiquiátrico (NPSLE), apoyando la función renal y reduciendo la inflamación. Este enfoque puede ayudar a manejar los casos graves de NPSLE de manera efectiva.

    Más Videos Relacionados

    Laser Microdissection-Based Protocol for the LC-MS/MS Analysis of the Proteomic Profile of Neuromelanin Granules
    07:35

    Laser Microdissection-Based Protocol for the LC-MS/MS Analysis of the Proteomic Profile of Neuromelanin Granules

    Published on: December 16, 2021

    2.4K
    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    15.5K

    Videos de Experimentos Relacionados

    Last Updated: Sep 9, 2025

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
    09:43

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

    Published on: June 8, 2022

    3.0K
    Laser Microdissection-Based Protocol for the LC-MS/MS Analysis of the Proteomic Profile of Neuromelanin Granules
    07:35

    Laser Microdissection-Based Protocol for the LC-MS/MS Analysis of the Proteomic Profile of Neuromelanin Granules

    Published on: December 16, 2021

    2.4K
    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    15.5K

    Área de la Ciencia:

    • Nefrología
    • Reumatología
    • Neuroinmunología

    Sus antecedentes:

    • El lupus eritematoso sistémico neuropsiquiátrico (LESPN) es una complicación grave del LES con opciones de tratamiento limitadas.
    • Los tratamientos actuales como el intercambio de plasma tienen riesgos significativos y desafíos logísticos.
    • Existe una necesidad crítica de estrategias terapéuticas alternativas para el manejo del NPSLE.

    Objetivo del estudio:

    • Investigar el potencial de la diálisis peritoneal (DP) como intervención terapéutica para el NPSLE.
    • Evaluar la eficacia de la PD en el tratamiento de los síntomas neuropsiquiátricos y la disfunción cardiorrenal en un paciente con NPSLE.
    • Explorar los cambios proteómicos en el dializado para comprender el mecanismo de acción de PD en NPSLE.

    Principales métodos:

    • Un informe de caso de una mujer de 42 años con LES que presentaba síntomas de NPSLE.
    • Iniciación de la diálisis peritoneal (DP) junto con el tratamiento inmunosupresor estándar (metilprednisolona, telitacicept, ciclofosfamida).
    • Análisis proteómico (LC-MS/MS) del dializado de PD para identificar las proteínas y vías eliminadas.

    Principales resultados:

    • La PD, combinada con inmunosupresores, condujo a la resolución de los síntomas neuropsiquiátricos y a la mejora de los parámetros renales y hematológicos.
    • El análisis proteómico identificó 518 proteínas en el dializado, con enriquecimiento en las vías de activación del complemento.
    • Se observó una desregulación significativa de los marcadores inflamatorios FCER2 (CD23) y de la proteína C reactiva (CRP), lo que sugiere la eliminación de los mediadores proinflamatorios.

    Conclusiones:

    • La diálisis peritoneal puede servir como una terapia de doble propósito para el NPSLE, proporcionando apoyo renal y modulando la hiperactivación del complemento.
    • PD demuestra potencial en la eliminación de los mediadores inflamatorios implicados en la patogénesis de NPSLE.
    • Este caso destaca la PD como una terapia complementaria prometedora para los casos graves de NPSLE.